课题基金 / 基金详情

Vascular Risk Factors in Alzheimer's Disease

Vascular Risk Factors in Alzheimer's Disease
阿尔茨海默病的血管危险因素
批准号:
7116909
负责人:
Gail Li
金额:
$12.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-01 至 2007-08-31

项目摘要

项目成果

Gail Li的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Candidate's Plan/Training: The Candidate plans a career as a patient-oriented clinical research investigator and academic geriatric psychiatrist bridging dementia, vascular risk factors and clinical epidemiology. Training will include formal didactics in lipid metabolism and augmentation of the Candidate's previous epidemiology training with additional advanced biostatistics and epidemiology courses and closely supervised completion of the research plan. Environment: The University of Washington Alzheimer's Disease Patient Registry (ADPR)/Adult Changes in Thought (ACT) and Alzheimer's Disease Research Center (ADRC) provide expertise in epidemiology, clinical dementia evaluation, and biostatistics to form an ideal research environment for epidemiological investigation of Alzheimer's disease (AD) and related dementias. Research: Recent studies suggest mid-life hypercholesterolemia and hypertension increase risk of dementia and specifically AD in late life. Cholesterol-lowering medications, the 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors, i.e., statins, may reduce the risk of AD. We hypothesize that vascular risk factors increase the risk of AD and/or vascular dementia (VaD) and use of statins reduces this risk. To address these hypotheses, Specific Aim 1 will determine whether the use of statins decreases the risk of AD and/or VaD, and whether these effects are modified by the presence of the Apolipoprotein Ee4 allele. We also investigate whether high serum low-density lipoprotein (LDL) and low serum high-density lipoprotein (HDL) are associated with increased risk for AD and/or VaD. Specific Aim 2 will determine if hypertension in older age (> 65 years) increases the risk of AD and/or VaD; we will also investigate blood pressure changes prior to the diagnosis of AD and/or VaD. A prospectively enrolled community-based cohort of 2581 initially cognitively normal elderly will provide the framework for this study. Results from the research project will provide insights into vascular risk factors for AD, thus providing additional information toward development of new prevention and treatment strategies. This research plan, together with the didactic and mentored instruction proposed, will provide the career development necessary for the candidate to conduct scientifically rigorous, independently funded, patient-oriented research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Air Pollution, the Aging Brain and Alzheimer's Disease
  • 批准号:
    9481174
  • 项目类别:
  • 资助金额:
    $3.91万
  • 财政年份:
    2016
  • 负责人:
    Gail Li
  • 依托单位:
Air Pollution, the Aging Brain and Alzheimer's Disease
  • 批准号:
    9175132
  • 项目类别:
  • 资助金额:
    $61.62万
  • 财政年份:
    2016
  • 负责人:
    Gail Li
  • 依托单位:
Air Pollution, the Aging Brain and Alzheimer's Disease
  • 批准号:
    9707467
  • 项目类别:
  • 资助金额:
    $35.54万
  • 财政年份:
    2016
  • 负责人:
    Gail Li
  • 依托单位:
Air Pollution, the Aging Brain and Alzheimer's Disease
  • 批准号:
    9753760
  • 项目类别:
  • 资助金额:
    $66.88万
  • 财政年份:
    2016
  • 负责人:
    Gail Li
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究